Modulation of the secretion of mesenchymal stem cell immunoregulatory factors by hydrolyzed fish collagen

Liu,Chao; Sun,Jiao

doi:10.3892/etm.2020.8674

Modulation of the secretion of mesenchymal stem cell immunoregulatory factors by hydrolyzed fish collagen

Authors:
- Chao Liu
- Jiao Sun
View Affiliations

Affiliations: Shanghai Biomaterials Research and Testing Center, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200023, P.R. China
Published online on: April 22, 2020 https://doi.org/10.3892/etm.2020.8674
Pages: 375-384
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the possible immunomodulatory effects of osteogenically differentiated bone marrow mesenchymal stem cells induced by hydrolyzed fish collagen. Marine biomaterials have attracted significant attention for their environmental friendliness and renewability. Hydrolyzed fish collagen (HFC) has been discovered to induce the osteoblastic differentiation of stem cells, which underlies the foundation for its application in tissue engineering. Stem cells and their biomaterial carriers face acute immune rejection mediated by host macrophages. A potential strategy for combatting rejection in stem cell therapy is to modify the polarization of macrophages. However, whether HFC‑induced mesenchymal stem cells maintain their immunomodulatory ability remains to be determined. To understand this phenomenon, a co‑culture model of direct contact was established between bone marrow mesenchymal stem cells (BMSCs) and RAW264.7 macrophages, where the secretion of nitrous oxide from macrophages was measured using Griess colorimetric assay. ELISAs were performed to measure the secretion of interleukin (IL)‑1β, IL‑6, transforming growth factor (TGF)‑β and IL‑10, whilst reverse transcription‑quantitative PCR was used to assess the expression levels of IL‑1β, IL‑6, CD206, resistin‑like molecule α (FIZZ1) and prostaglandin E2 receptor 4 (EP4). In addition, the expression levels of relevant proteins in the phosphorylated‑cyclic AMP‑responsive element‑binding protein‑CCAAT/enhancer‑binding protein β (EBPβ) pathway were investigated using western blotting. HFC‑induced BMSCs were found to suppress the expression levels of IL‑1β and IL‑6, whilst increasing the expression levels of CD206 and FIZZ1 in RAW264.7 macrophages. HFC‑induced BMSCs also inhibited the secretion of IL‑1β and IL‑6, whilst promoting the secretion of TGF‑β and IL‑10 secretion from RAW264.7 macrophages. Mechanistic studies using western blotting discovered that HFC stimulated the secretion of prostaglandin E2 from BMSCs, which subsequently increased the expression of EP4 on the macrophages. EP4 then increased the expression levels of C/EBPβ and arginase 1 further. In conclusion, results from the present study suggested that following induction with HFC, BMSCs maintain their immunomodulatory activity.

View Figures

View References

1	Mantha S, Pillai S, Khayambashi P, Upadhyay A, Zhang Y, Tao O, Pham HM and Tran SD: Smart hydrogels in tissue engineering and regenerative medicine. Materials (Basel). 12(pii: E3323)2019.PubMed/NCBI View Article : Google Scholar
2	Costa-Almeida R, Calejo I and Gomes ME: Mesenchymal stem cells empowering tendon regenerative therapies. Int J Mol Sci. 2(pii: E3002)2019.PubMed/NCBI View Article : Google Scholar
3	Crupi A, Costa A, Tarnok A, Melzer S and Teodori L: Inflammation in tissue engineering: The Janus between engraftment and rejection. Eur J Immunol. 45:3222–3236. 2015.PubMed/NCBI View Article : Google Scholar
4	Przekora A: The summary of the most important cell-biomaterial interactions that need to be considered during in vitro biocompatibility testing of bone scaffolds for tissue engineering applications. Mater Sci Eng C Mater Biol Appl. 97:1036–1051. 2019.PubMed/NCBI View Article : Google Scholar
5	Liu C and Sun J: Potential application of hydrolyzed fish collagen for inducing the multidirectional differentiation of rat bone marrow mesenchymal stem cells. Biomacromolecules. 15:436–443. 2014.PubMed/NCBI View Article : Google Scholar
6	Blanco M, Vázquez JA, Pérez-Martín RI and Sotelo CG: Hydrolysates of fish skin collagen: An opportunity for valorizing fish industry byproducts. Mar Drugs. 15(pii: E131)2017.PubMed/NCBI View Article : Google Scholar
7	Liu C and Sun J: Hydrolyzed tilapia fish collagen induces osteogenic differentiation of human periodontal ligament cells. Biomed Mater. 10(065020)2015.PubMed/NCBI View Article : Google Scholar
8	Raabe O, Reich C, Wenisch S, Hild A, Burg-Roderfeld M, Siebert HC and Arnhold S: Hydrolyzed fish collagen induced chondrogenic differentiation of equine adipose tissue-derived stromal cells. Histochem Cell Biol. 134:545–554. 2010.PubMed/NCBI View Article : Google Scholar
9	Liu C, Liu X, Xue Y, Ding TT and Sun J: Hydrolyzed tilapia fish collagen modulates the biological behavior of macrophages under inflammatory conditions. RSC Adv. 5:30727–30736. 2015.
10	Rackham CL and Jones PM: Potential of mesenchymal stromal cells for improving islet transplantation outcomes. Curr Opin Pharmacol. 43:34–39. 2018.PubMed/NCBI View Article : Google Scholar
11	Mukherjee S, Darzi S, Paul K, Werkmeister JA and Gargett CE: Mesenchymal stem cell-based bioengineered constructs: Foreign body response, cross-talk with macrophages and impact of biomaterial design strategies for pelvic floor disorders. Interface Focus. 9(20180089)2019.PubMed/NCBI View Article : Google Scholar
12	Yang M and Liu L: MHC II gene knockout in tissue engineering may prevent immune rejection of transplants. Med Hypotheses. 70:798–801. 2008.PubMed/NCBI View Article : Google Scholar
13	Weston LE, Geczy AF and Briscoe H: Production of IL-10 by alloreactive sibling donor cells and its influence on the development of acute GVHD. Bone Marrow Transplant. 37:207–212. 2006.PubMed/NCBI View Article : Google Scholar
14	Sica A and Mantovani A: Macrophage plasticity and polarization: In vivo veritas. J Clin Invest. 122:787–795. 2012.PubMed/NCBI View Article : Google Scholar
15	Ben-Mordechai T, Palevski D, Glucksam-Galnoy Y, Elron-Gross I, Margalit R and Leor J: Targeting macrophage subsets for infarct repair. J Cardiovasc Pharmacol Ther. 20:36–51. 2015.PubMed/NCBI View Article : Google Scholar
16	Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, Seifi B, Mohammadi A, Afshari JT and Sahebkar A: Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 233:6425–6440. 2018.PubMed/NCBI View Article : Google Scholar
17	Bernardo ME and Fibbe WE: Mesenchymal stromal cells and hematopoietic stem cell transplantation. Immunol Lett. 168:215–221. 2015.PubMed/NCBI View Article : Google Scholar
18	Deng W, Chen W, Zhang Z, Huang S, Kong W, Sun Y, Tang X, Yao G, Feng X, Chen W and Sun L: Mesenchymal stem cells promote CD206 expression and phagocytic activity of macrophages through IL-6 in systemic lupus erythematosus. Clin Immunol. 161:209–216. 2015.PubMed/NCBI View Article : Google Scholar
19	Abumaree MH, Al Jumah MA, Kalionis B, Jawdat D, Al Khaldi A, Abomaray FM, Fatani AS, Chamley LW and Knawy BA: Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from inflammatory M1 to anti-inflammatory M2 macrophages. Stem Cell Rev Rep. 9:620–641. 2013.PubMed/NCBI View Article : Google Scholar
20	Kim J and Hematti P: Mesenchymal stem cell-educated macrophages: A novel type of alternatively activated macrophages. Exp Hematol. 37:1445–1453. 2009.PubMed/NCBI View Article : Google Scholar
21	Ripoll CB, Flaat M, Klopf-Eiermann J, Fisher-Perkins JM, Trygg CB, Scruggs BA, McCants ML, Leonard HP, Lin AF, Zhang S, et al: Mesenchymal lineage stem cells have pronounced anti-inflammatory effects in the twitcher mouse model of Krabbe's disease. Stem Cells. 29:67–77. 2011.PubMed/NCBI View Article : Google Scholar
22	Bianco P, Riminucci M, Gronthos S and Robey PG: Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells. 19:180–192. 2001.PubMed/NCBI View Article : Google Scholar
23	Polymeri A, Giannobile WV and Kaigler D: Bone marrow stromal stem cells in tissue engineering and regenerative medicine. Horm Metab Res. 48:700–713. 2016.PubMed/NCBI View Article : Google Scholar
24	Wallace CS and Truskey GA: Direct-contact co-culture between smooth muscle and endothelial cells inhibits TNF-alpha-mediated endothelial cell activation. Am J Physiol Heart Circ Physiol. 299:H338–H346. 2010.PubMed/NCBI View Article : Google Scholar
25	Livak JK and Schmittgen TD: Analysis of relative gene expression data using quantitative PCR and the 2-ΔΔCt method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
26	Shujia J, Haider HK, Idris NM, Lu G and Ashraf M: Stable therapeutic effects of mesenchymal stem cell-based multiple gene delivery for cardiac repair. Cardiovasc Res. 77:525–533. 2008.PubMed/NCBI View Article : Google Scholar
27	Secunda R, Vennila R, Mohanashankar AM, Rajasundari M, Jeswanth S and Surendran R: Isolation, expansion and characterisation of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: A comparative study. Cytotechnology. 67:793–807. 2015.PubMed/NCBI View Article : Google Scholar
28	Climaco-Arvizu S, Domínguez-Acosta O, Cabañas-Cortés MA, Rodríguez-Sosa M, Gonzalez FJ, Vega L and Elizondo G: Aryl hydrocarbon receptor influences nitric oxide and arginine production and alters M1/M2 macrophage polarization. Life Sci. 155:76–84. 2016.PubMed/NCBI View Article : Google Scholar
29	Arndt L, Dokas J, Gericke M, Kutzner CE, Müller S, Jeromin F, Thiery J and Burkhardt R: Tribbles homolog 1 deficiency modulates function and polarization of murine bone marrow-derived macrophages. J Biol Chem. 293:11527–11536. 2018.PubMed/NCBI View Article : Google Scholar
30	Michelo CM, Fasse E, van Cranenbroek B, Linda K, van der Meer A, Abdelrazik H and Joosten I: Added effects of dexamethasone and mesenchymal stem cells on early Natural Killer cell activation. Transpl Immunol. 37:1–9. 2016.PubMed/NCBI View Article : Google Scholar
31	Albu DI, Wang Z, Huang KC, Wu J, Twine N, Leacu S, Ingersoll C, Parent L, Lee W, Liu D, et al: EP4 Antagonism by E7046 diminishes Myeloid immunosuppression and synergizes with Treg-reducing IL-2-Diphtheria toxin fusion protein in restoring anti-tumor immunity. Oncoimmunology. 6(e1338239)2017.PubMed/NCBI View Article : Google Scholar
32	Mattes B and Scholpp S: Emerging role of contact-mediated cell communication in tissue development and diseases. Histochem Cell Biol. 150:431–442. 2018.PubMed/NCBI View Article : Google Scholar
33	Rahimzadeh A, Mirakabad FS, Movassaghpour A, Shamsasenjan K, Kariminekoo S, Talebi M, Shekari A, Zeighamian V, Ghalhar MG and Akbarzadeh A: Biotechnological and biomedical applications of mesenchymal stem cells as a therapeutic system. Artif Cells Nanomed Biotechnol. 44:559–570. 2016.PubMed/NCBI View Article : Google Scholar
34	Liu C and Sun J: Osteogenically differentiated mesenchymal stem cells induced by hydrolyzed fish collagen maintain their immunomodulatory effects. Life Sci. 238(116970)2019.PubMed/NCBI View Article : Google Scholar
35	Abdelrazik H, Spaggiari GM, Chiossone L and Moretta L: Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function. Eur J Immunol. 41:3281–3290. 2011.PubMed/NCBI View Article : Google Scholar
36	Duffy MM, Ritter T, Ceredig R and Griffin MD: Mesenchymal stem cell effects on T-cell effector pathways. Stem Cell Res Ther. 2(34)2011.PubMed/NCBI View Article : Google Scholar
37	Mills CD: M1 and M2 Macrophages: Oracles of health and disease. Crit Rev Immunol. 32:463–488. 2012.PubMed/NCBI View Article : Google Scholar
38	Varela P, Sartori S, Viebahn R, Salber J and Ciardelli G: Macrophage immunomodulation: An indispensable tool to evaluate the performance of wound dressing biomaterials. J Appl Biomater Funct Mater. 17(2280800019830355)2019.PubMed/NCBI View Article : Google Scholar
39	Mueller CK and Schultze-Mosgau S: Histomorphometric analysis of the phenotypical differentiation of recruited macrophages following subcutaneous implantation of an allogenous acellular dermal matrix. Int J Oral Maxillofac Surg. 40:401–407. 2011.PubMed/NCBI View Article : Google Scholar
40	Dinarello CA: Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 27:519–550. 2009.PubMed/NCBI View Article : Google Scholar
41	Nishimoto N: Interleukin-6 as a therapeutic target in candidate inflammatory diseases. Clin Pharmacol Ther. 87:483–487. 2010.PubMed/NCBI View Article : Google Scholar
42	Batlle E and Massagué J: Transforming Growth Factor-β Signaling in Immunity and Cancer. Immunity. 50:924–940. 2019.PubMed/NCBI View Article : Google Scholar
43	Gorelik L and Flavell RA: Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells. Nat Med. 7:1118–1122. 2001.PubMed/NCBI View Article : Google Scholar
44	Steen EH, Wang X, Balaji S, Butte MJ, Bollyky PL and Keswani SG: the role of the anti-inflammatory cytokine interleukin-10 in tissue fibrosis. Adv Wound Care (New Rochelle). 9:184–198. 2020.PubMed/NCBI View Article : Google Scholar
45	Mittal SK and Roche PA: Suppression of antigen presentation by IL-10. Curr Opin Immunol. 34:22–27. 2015.PubMed/NCBI View Article : Google Scholar
46	Ferrante CJ, Pinhal-Enfield G, Elson G, Cronstein BN, Hasko G, Outram S and Leibovich SJ: The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4Rα) signaling. Inflammation. 36:921–931. 2013.PubMed/NCBI View Article : Google Scholar
47	Boehler RM, Kuo R, Shin S, Goodman AG, Pilecki MA, Gower RM, Leonard JN and Shea LD: Lentivirus delivery of IL-10 to promote and sustain macrophage polarization towards an anti-inflammatory phenotype. Biotechnol Bioeng. 111:1210–1221. 2014.PubMed/NCBI View Article : Google Scholar
48	Ylöstalo JH, Bartosh TJ, Coble K and Prockop DJ: Human mesenchymal stem/stromal cells cultured as spheroids are self-activated to produce prostaglandin E2 that directs stimulated macrophages into an anti-inflammatory phenotype. Stem Cells. 30:2283–2296. 2012.PubMed/NCBI View Article : Google Scholar